Evidence map›Paper›PMID 30447521›Full record

ArticleColloids and surfaces. B, Biointerfaces2019

PEG-b-poly (carbonate)-derived nanocarrier platform with pH-responsive properties for pancreatic cancer combination therapy.

Priyanka Ray, Matthew Confeld, Pawel Borowicz, Tao Wang, Sanku Mallik, Mohiuddin Quadir

Open access · greenAbstract read
In one paragraph

Article in Colloids and surfaces. B, Biointerfaces, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 79 citations in OpenAlex.

  1. Review
  2. Article
  3. Enhancing immunotherapy with tumour-responsive nanomaterials.Nature reviews. Clinical oncology · 2025
    Review
  4. Review
  5. Article
  6. Article
  7. Recent advances in drug delivery and targeting for the treatment of pancreatic cancer.Journal of controlled release : official journal of the Controlled Release Society · 2024
    Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Priyanka RayDepartment of Coatings and Polymeric Materials, North Dakota State University, Fargo, ND, USA.
Matthew ConfeldDepartment of Pharmaceutical Sciences, North Dakota State University, Fargo, ND, USA.
Pawel BorowiczDepartment of Animal Sciences, North Dakota State University, Fargo, ND, USA.
Tao WangCore Biology Facility, North Dakota State University, Fargo, ND, USA.
Sanku MallikDepartment of Pharmaceutical Sciences, North Dakota State University, Fargo, ND, USA. Electronic address: sanku.mallik@ndsu.edu.
Mohiuddin QuadirDepartment of Coatings and Polymeric Materials, North Dakota State University, Fargo, ND, USA. Electronic address: mohiuddin.quadir@ndsu.edu.
North Dakota State University · US

Funding

Targeting CLEC-2/podoplanin as a therapeutic strategy for pancreatic cancerP20GM109024 · NIGMS · NORTH DAKOTA STATE UNIVERSITY · PI Sanku Mallik · 2016 to 2026
$20.5M
TARGETING AND DELIVERYP20RR015566 · NCRR · NORTH DAKOTA STATE UNIVERSITY · PI SIBI, MUKUND P. · 2001 to 2011
$19.0M
Echogenic Polymersomes for Triggered Contents ReleaseR01GM114080 · NIGMS · NORTH DAKOTA STATE UNIVERSITY · PI MALLIK, SANKU, SARKAR, KAUSIK · 2015 to 2023
$2.6M
NCRR NIH HHS P20 RR015566NIGMS NIH HHS P20 GM109024NIGMS NIH HHS R01 GM114080
6 · The paper itself

Abstract

A pH-responsive nanoparticle platform, based on PEG-b-poly (carbonate) block copolymers have been proposed that can respond to low pH as found in many cancer micro- and intracellular environment, including that in pancreatic cancer. The hydrophobic domain, i.e., the poly (carbonate) segment has been substituted with tertiary amine side chains, such as N, N'-dibutylethylenediamine (pK

Indexed as

Drug Delivery SystemsAnilidesAnimalsAntineoplastic Combined Chemotherapy ProtocolsApoptosisCell ProliferationDeoxycytidineDrug CarriersGemcitabineHumansHydrogen-Ion ConcentrationMiceMicellesMice, NudeNanoparticlesPancreatic NeoplasmsAnilidesDeoxycytidineDrug CarriersGemcitabineHhAntag691MicellespolycarbonatePolycarboxylate CementPolyethylene GlycolsPolymersPyridinesBlock copolymersColloidsDrug deliveryNanoparticlesPancreatic cancerpH-responsive nanocarriers

Identifiers

PMID30447521
PMCPMC6369007
OpenAlexW2898386214

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.